(Q24244303)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

1 reference

title

Nitric oxide for respiratory failure in infants born at or near term (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

N N Finer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

18 October 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

CD000399

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

A randomized trial of early versus standard inhaled nitric oxide therapy in term and near-term newborn infants with hypoxic respiratory failure.

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Inhaled nitric oxide and persistent pulmonary hypertension of the newborn. The Inhaled Nitric Oxide Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Inhaled nitric oxide in the treatment of moderate persistent pulmonary hypertension of the newborn: a randomized controlled, multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Child health status, neurodevelopmental outcome, and parental satisfaction in a randomized, controlled trial of nitric oxide for persistent pulmonary hypertension of the newborn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Apparent hydroxyl radical production by peroxynitrite: implications for endothelial injury from nitric oxide and superoxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

The pharmacology of inhaled nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Chronic nitric oxide inhibition in utero produces persistent pulmonary hypertension in newborn lambs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Inhaled nitric oxide. A selective pulmonary vasodilator reversing hypoxic pulmonary vasoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Time-course and dose-response of nitric oxide inhalation for systemic oxygenation and pulmonary hypertension in patients with adult respiratory distress syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Prolonged bleeding time during nitric oxide inhalation in the rabbit.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Neurodevelopmental and medical outcomes of persistent pulmonary hypertension in term newborns treated with nitric oxide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Improvement in VA/Q distributions during inhalation of nitric oxide in pigs with methacholine-induced bronchoconstriction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Delayed effects of NO2 exposure on alveolar permeability and glutathione peroxidase in healthy humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Inhaled nitric oxide in persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Inhaled nitric oxide reverses pulmonary vasoconstriction in the hypoxic and acidotic newborn lamb.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Longitudinal follow-up of a cohort of newborn infants treated with inhaled nitric oxide for persistent pulmonary hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Dependence of the metabolism of nitric oxide (NO) in healthy human whole blood on the oxygenation of its red cell haemoglobin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Biotransformation of nitric oxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

Infant lung function after inhaled nitric oxide therapy for persistent pulmonary hypertension of the newborn

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Bleeding time prolongation and NO inhalation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Safety requirement for use of inhaled nitric oxide in neonates

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

L-arginine is the physiological precursor for the formation of nitric oxide in endothelium-dependent relaxation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide in infants referred for extracorporeal membrane oxygenation: dose response

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide in term infants with hypoxemic respiratory failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide for the adult respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide in full-term and nearly full-term infants with hypoxic respiratory failure

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Low-Dose Nitric Oxide Therapy for Persistent Pulmonary Hypertension of the Newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide in term and near-term infants: neurodevelopmental follow-up of the neonatal inhaled nitric oxide study group (NINOS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Effects of higher oxides of nitrogen on the anaesthetized dog

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled Nitric Oxide A Selective Pulmonary Vasodilator of Heparin-Protamine Vasoconstriction in Sheep

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide reduces the utilization of extracorporeal membrane oxygenation in persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide reduces the need for extracorporeal membrane oxygenation in infants with persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Methaemoglobinaemia with high-dose nitric oxide administration

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide reverses hypoxic pulmonary vasoconstriction without impairing gas exchange

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Nitric oxide reverses acute hypoxic pulmonary hypertension in the newborn piglet

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Improved oxygenation in a randomized trial of inhaled nitric oxide for persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide for the early treatment of persistent pulmonary hypertension of the term newborn: a randomized, double-masked, placebo-controlled, dose-response, multicenter study. The I-NO/PPHN Study Group

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Randomized, controlled trial of low-dose inhaled nitric oxide in the treatment of term and near-term infants with respiratory failure and pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

Inhaled nitric oxide and hypoxic respiratory failure in infants with congenital diaphragmatic hernia. The Neonatal Inhaled Nitric Oxide Study Group (NINOS)

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD000399.PUB2

7 January 2021

10.1002/14651858.CD000399.PUB2

Identifiers

DOI

2 references

Consolidated OpenCitations Corpus – April 2017

4982162

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17054129%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

4982162

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

2 references

4982162